Effects of segregation on an epidemic Pseudomonas aeruginosa strain in a cystic fibrosis clinic

American Journal of Respiratory and Critical Care Medicine

Volumn 171, Issue 9, 2005, Pages 1020-1025

  Griffiths, Amanda L ^b   Jamsen, Kris ^b   Carlin, John B ^b   Grimwood, Keith ^b   Carzino, Rosemary ^b   Robinson, Philip J ^b   Massie, John ^b   Armstrong, David S ^a  

^a MONASH UNIVERSITY   (Australia)

^b NONE

Author keywords

Cross infection; Cystic fibrosis; Infection control; Pseudomonas aeruginosa

Indexed keywords

ADOLESCENT; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; CHILD; CROSS INFECTION; CYSTIC FIBROSIS; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ADOLESCENT; BACTERIAL TYPING TECHNIQUES; CHILD; COHORT STUDIES; COMORBIDITY; CROSS INFECTION; CYSTIC FIBROSIS; DISEASE OUTBREAKS; FEMALE; HUMANS; INFECTION CONTROL; MALE; PREVALENCE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SPUTUM; VIRULENCE;

EID: 18144422424     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200409-1194OC     Document Type: Article

References (43)

1. Schaedel C, de Monestrol I, Hjelte L, Johannesson M, Kornfalt R, Lindblad A, Strandvik B, Wahlgren L, Holmberg L. Predictors of deterioration of lung function in cystic fibrosis. Pediatr Pulmonol 2002;33:483-491.
2. Henry RL, Mellis CM, Petrovic L. Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis. Pediatr Pulmonol 1992;12:158-161.
3. Ogle JW, Janda JM, Woods DE, Vasil ML. Characterization and use of a DNA probe as an epidemiological marker for Pseudomonas aeruginosa. J Infect Dis 1987;155:119-126.
4. Speert DP, Campbell ME, Farmer SW, Volpel K, Joffe AM, Paranchych W. Use of a pilin gene probe to study molecular epidemiology of Pseudomonas aeruginosa. J Clin Microbiol 1989;27:2589-2593.
5. Speert DP, Campbell ME, Henry DA, Milner R, Tana F, Gravelle A, Davidson AGF, Wong LTK, Mahenthiralingam E. Epidemiology of Pseudomonas aeruginosa in cystic fibrosis in British Columbia, Canada. Am J Respir Crit Care Med 2002;166:988-993.
6. Romling U, Wingender J, Muller H, Tummler B. A major Pseudomonas aeruginosa clone common to patients and aquatic habitats. Appl Environ Microbiol 1994;60:1734-1738.
7. Cheng K, Smyth RL, Govan JRW, Doherty C, Winstanley C, Denning N, Heat DP, van Saene H, Hart CA. Spread of β-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet 1996;348:639-642.
8. Jones AM, Govan JR, Doherty CJ, Dodd ME, Isalska BJ, Stanbridge TN, Webb AK. Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet 2001;358:558-560.
9. Armstrong D, Bell S, Robinson M, Bye P, Rose B, Harbour C, Lee C, Service H, Nissen M, Syrmis M, et al. Evidence for spread of a clonal strain of Pseudomonas aeruginosa among cystic fibrosis clinics. J Clin Microbiol 2003;41:2266-2267.
10. Scott FW, Pitt TL. Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England Wales. J Med Microbiol 2004;53:609-615.
11. Nixon GM, Armstrong DS, Carzino R, Carlin JB, Olinsky A, Robertson CF, Grimwood K. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr 2001;138:699-704.
12. Armstrong DS, Nixon GM, Carzino R, Bigham A, Carlin JB, Robins-Browne RM, Grimwood K. Detection of a widespread clone of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic. Am J Respir Crit Care Med 2002;166:983-987.
13. Frederiksen BKC, Hoiby N. Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients (1974-1995). Pediatr Pulmonol 1999;28:159-166.
14. Ledson MJ, Gallagher MJ, Corkhill JE, Hart CA, Walshaw MJ. Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia. Thorax 1998;53:432-436.
15. Griffiths AL, Robinson P, Carzino R, Grimwood K, Carlin J, Jamsen K, Armstrong D. Melbourne clonal strain of Pseudomonas aeruginosa since cohort segregation [abstract]. Pediatr Pulmonol 2003;36(Suppl 25):A345.
16. Taussig LM, Kattwinkel J, Friedewald WT, di Sant'Agnese P. A new prognostic score and clinical evaluation system for cystic fibrosis. J Pediatr 1973;82:380-390.
17. Massie RJ, Olsen M, Glazner J, Robertson CF, Francis I. Newborn screening for cystic fibrosis in Victoria: 10 years' experience (1989-1998). Med J Aust 2000;172:584-587.
18. Armstrong DS, Grimwood K, Carlin JB, Carzino R, Gutierrez JP, Hull J, Olinsky A, Phelan EM, Robertson CF, Phelan PD. Lower airway inflammation in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 1997;156:1197-1204.
19. Wahba AH, Darrell JH. The identification of atypical strains of Pseudomonas aeruginosa. J Gen Microbiol 1965;38:329-342.
20. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing: Twelfth International Supplement M100-S12. Wayne, PA: National Committee for Clinical Laboratory Standards; 2002.
21. Armstrong DS, Grimwood K, Carzino R, Carlin JB, Olinsky A, Phelan PD. Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis. Pediatr Pulmonol 1996;21:267-275.
22. Tenover FC, Arbeit RD, Goering RV. Interpreting chromosomal DNA restriction fragments produced by pulse-field gel electrophoresis: Criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233-2239.
23. Stata statistical software [computer program]. Release 5.0. College Station, TX: Stata Corporation. Release 8.0 2003.
24. Cystic Fibrosis Foundation. Microbiology and infectious diseases in cystic fibrosis. Consensus conference: concepts in care. Vol. 5, section 1. Bethesda, MD: Cystic Fibrosis Foundation; 1994.
25. Saiman L, Siegel J, and the Cystic Fibrosis Foundation Consensus Conference on Infection Control Participants. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Am J Infect Control 2003;31:S1-S62.
26. Jones AM, Webb AK. Recent advances in cross-infection in cystic fibrosis: Burkholderia cepacia complex, Pseudotnonas aeruginosa, MRSA and Pandoraea spp. J R Soc Med 2003;96:66-72.
27. Tubbs D, Lenney W, Alcock CA, Campbell J, Gray J, Pantin C. Pseudomonas aeruginosa in cystic fibrosis: cross-infection and the need for segregation. Respir Med 2001;95:147-152.
28. O'Carroll MR, Syrmis MW, Wainwright CE, Greer RM, Mitchell P, Coulter C, Sloots TP, Nissen MD, Bell SC. Clonal strains of Pseudomonas aeruginosa in paediatric and adult cystic fibrosis units. Eur Respir J 2004;24:101-106.
29. Ojeniyi B, Fredericksen B, Hoiby N. Pseudomonas aeruginosa cross-infection among patients with cystic fibrosis during a winter camp. Pediatr Pulmonol 2000;29:177-181.
30. Lee TWR, Brownlee KG, Denton M, Littlewood JM, Conway SP. Reduction in prevalence of chronic Pseudomonas aeruginosa infection at a regional pediatric cystic fibrosis center. Pediatr Pulmonol 2004;37:104-110.
31. Krogh Johansen H, Norregaard L, Gotzsche PC, Pressler T, Koch C, Hoiby N. Antibody response to Pseudomonas aeruginosa in cystic fibrosis patients: a marker of therapeutic success? A 30-year cohort study of survival in Danish CF patients after onset of chronic P. aeruginosa lung infection. Pediatr Pulmonol 2004;37:427-432.
32. McCallum SJ, Corkill J, Gallagher M, Ledson MJ, Hart CA, Walshaw MJ. Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonized by P. aeruginosa. Lancet 2001;358:558-560.
33. Robinson P, Carzino R, Armstrong D, Olinsky A. Pseudomonas cross-infection from cystic fibrosis patients: implications for inpatient care of respiratory patients. J Clin Microbiol 2003;41:5741.
34. Davies G, McShane D, Davies JC, Bush A. Multiresistant Pseudomonas aeruginosa in a pediatric cystic fibrosis center: natural history and implications for segregation. Pediatr Pulmonol 2003;35:253-256.
35. Griffiths AL, Armstrong D, Carzino R, Robinson P. Cystic fibrosis patients and families support cross-infection measures. Eur Respir J 2004;24:449-452.
36. Al-Aloul M, Crawley J, Winstanley C, Hart CA, Ledson MJ, Walshaw MJ. Increased morbidity with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients. Thorax 2004;59:334-336.
37. Demko CA, Byard PA, Davis PB. Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. J Clin Epidemiol 1995;48:1041-1049.
38. Jones AM, Dodd ME, Doherty CJ, Govan JRW, Webb AK. Increased treatment requirements of patients with cystic fibrosis who harbour a highly transmissible strain of Pseudomonas aeruginosa. Thorax 2002;57:924-925.
39. Al-Samarrai TH, Zhang N, Lamont IL, Martin L, Kolbe J, Wilsher M, Morris AJ, Schmid J. Simple and inexpensive but highly discriminating method for computer-assisted DNA fingerprinting of Pseudomonas aeruginosa. J Clin Microbiol 2001;38:4445-4452.
40. Jung A, Kleinau I, Schonian G, Bauernfeind A, Chen C, Griese M, Doring G, Gobel U, Wahn U, Paul K. Sequential genotyping of Pseudomonas aeruginosa from upper and lower airways of cystic fibrosis patients. Eur Respir J 2002;20:1457-1463.
41. Aaron SD. Kottachchi, Ferris WJ, Vandemheen KL, St. Dennis ML, Plouffe A, Doucette SP, Saginur R, Chan FT, Ramotar K. Sputum versus bronchoscopy for diagnosis of Pseudomonas aeruginosa biofilms in cystic fibrosis. Eur Respir J 2004;24:631-637.
42. Rosenfeld M, Emerson J, Accurso F, Armstrong D, Castile R, Grimwood K, Hiatt P, McCoy K, McNamara S, Ramsey B, et al. Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatr Pulmonol 1999;28:321-328.
43. Hoiby N, Pedersen SS. Estimated risk of cross-infection with Pseudomonas aeruginosa in Danish cystic fibrosis patients. Acta Paediatr Scand 1989;78:395-404.